This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.

生物检测开发顾问将被要求评估或开发生物检测开发计划，并推荐优化检测和/或鉴定/验证检测的策略和实验，以用于临床和非临床研究。生物检测顾问可能会被要求协助建立与检测优化或验证相关的里程碑。生物测定可用于在生产研究中和/或在从临床和/或非临床研究中获得的血清或组织样本中测量药物产品。NIH可能会在设计和解释常用的体外分析方法(如生化和/或基于细胞的分析)方面寻求顾问的指导。具体的咨询责任将取决于个别顾问的专业知识和个别项目的需要。与生物测定相关的咨询服务可能需要临时提供，也可能需要通过LDTS提供。

Bioassay development consultants will be required to evaluate or develop bioassay development plans and recommend strategies and experiments to optimize assays and/or qualify/validate the assays, for use in a clinical and nonclinical studies. Bioassay consultants may be asked to assist in the establishment of milestones related to assay optimization or validation. Bioassays may be used to measure drug product in manufacturing studies, and/or in serum or tissue samples obtained from clinical and/or nonclinical studies. The NIH may seek guidance from consultants on the design and interpretation of commonly used in vitro assays, such as biochemical and/or cell-based assays. Specific consulting responsibilities will depend on the expertise of the individual consultant and the needs of individual projects. Bioassay-related consultation services may be required on an ad hoc basis or on LDTs.